RNA-seq (GSE66763) and qPCR results showed that CD4+ T cells from healthy control individuals expressed high amounts of RNF213, whereas expression was reduced in CD4+ T cells from patients with MS, especially in MOG-specific CD4+ T cells (Fig. 7F, G). The gene discussed is RNF213; the disease is myeloid sarcoma.